Akhil Chawla

8PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersGeneral practiceCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

|Jul 23, 2025
A Conceptual Framework on Integrating a Large and Growing Academic Health System.

Akhil Chawla, Fabian M Johnston, Michael J Rosen

|Mar 06, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Lakshmi Rajdev, Gentry G King, Christopher H Lieu

|Oct 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy.

Dominic J Vitello, Dhavan Shah, Amy Wells

|Jun 03, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA.

Qiang Zhang, Zheng Cai, Lorenzo Gerratana

|Sep 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.

Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla

Pageof 2

Frequent Collaborators

2 joint publications

Qiang Zhang

1 joint publications

Nicholas Sich

1 joint publications

Andressa Dias Costa

1 joint publications

Sara A Väyrynen